Posted on 09/20/2023 8:25:03 PM PDT by ConservativeMind
Investigators have found that dasatinib, a drug commonly used to treat chronic myeloid leukemia, is strongly associated with kidney injury.
The study team strongly believes this study will impact clinical practice significantly, changing standard of care and possibly introducing new black box warnings for dasatinib.
Furthermore, the researchers point out that the incidence of kidney injury is a previously unknown severe side effect for this drug. This side effect, they report, is advertised to be rare; however, they observed it in 10% of all participants taking dasatinib. Of concern, they say, is that patients taking dasatinib are currently not screened for kidney injury or dysfunction, making them susceptible to chronic kidney disease.
The study included 82 participants who have been on long-term tyrosine-kinase inhibitor treatment for chronic myeloid leukemia; 32 participants were treated with dasatinib and 50 were treated with other, similar drugs.
Significantly elevated levels of kidney injury (measured as elevated protein in the urine, or proteinuria) were identified in the dasatinib patients, with 10% of participants exhibiting severe levels that were later seen to decrease upon cessation of dasatanib use. No participant in the non-dasatinib cohort showed severe proteinuria. Widespread kidney damage in dasatinib patients was also confirmed by kidney biopsy.
The investigators examined glomerular injury through urine albumin-creatinine ratio (UACR) in the 82 patients with chronic myelogenous leukemia who had been continuously taking a tyrosine-kinase inhibitor for at least 90 days. They compared mean differences in UACR, in addition to studying proteinuria. In addition to other blood tests, they also described a case study of a patient who experienced nephrotic-range proteinuria while on dasatinib.
Based on these findings, oncologists prescribing dasatinib may be advised to monitor patients for kidney function or proteinuria and engage a nephrologist to assist in their care.
(Excerpt) Read more at medicalxpress.com ...
Upon stopping dasatinib, only a portion of kidney function came back.
Doctors apparently don’t know this is causing kidney issues.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.